Literature DB >> 7118251

Lymphocyte-mediated immune cytotoxicity in dogs infected with virulent canine distemper virus.

M J Appel, W R Shek, B A Summers.   

Abstract

Immune lymphocyte-mediated cytotoxicity (ILMC) was evaluated in dogs after intranasal exposure to one of the following three virulent strains of canine distemper virus: Cornell A75/17, Ohio R252, and Snyder Hill. Cytotoxicity was tested with peripheral blood lymphocytes as effector cells and primary dog testicle cells that were matched for histocompatibility as target cells. A strong correlation was found between ILMC and the course of the infection. Dogs that succumbed to encephalitis with any of the strains had little or no ILMC, whereas dogs that recovered had the highest activity. In the intermediate range were dogs with a delayed or reduced ILMC which developed persistent but subclinical central nervous system infections. A significant difference in onset, peak, and duration of ILMC was observed in dogs infected with different strains of canine distemper virus. ILMC responses began at 14 days postinfection (p.i.), reached a peak at 21 to 28 days p.i., and returned to preinoculation levels by 63 to 70 days p.i. in canine distemper virus A75/17- and R252-infected dogs. In contrast, ILMC in canine distemper virus Snyder Hill-infected dogs began at 10 days p.i., peaked by 14 to 17 days p.i., and approached preinoculation levels by 28 days p.i. Antiviral immunity as measured by ILMC appears to be a critical factor in determining the outcome in canine distemper virus-infected hosts. Furthermore, for certain viral biotypes, a delayed ILMC response correlated with persistent infection of the central nervous system.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7118251      PMCID: PMC347574          DOI: 10.1128/iai.37.2.592-600.1982

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  23 in total

Review 1.  T-cell-mediated immunopathology in viral infections.

Authors:  P C Doherty; R M Zinkernagel
Journal:  Transplant Rev       Date:  1974

2.  Experimental canine distemper virus-induced demyelination.

Authors:  B McCullough; S Krakowka; A Koestner
Journal:  Lab Invest       Date:  1974-09       Impact factor: 5.662

3.  Demyelinating activity of canine distemper virus isolates in gnotobiotic dogs.

Authors:  B McCullough; S Krakowka; A Koestner; J Shadduck
Journal:  J Infect Dis       Date:  1974-10       Impact factor: 5.226

4.  Pathogenesis of canine distemper.

Authors:  M J Appel
Journal:  Am J Vet Res       Date:  1969-07       Impact factor: 1.156

5.  Effects of canine distemper virus infection on lymphoid function in vitro and in vivo.

Authors:  S Krakowka; G Cockerell; A Koestner
Journal:  Infect Immun       Date:  1975-05       Impact factor: 3.441

6.  A microneutralization test for canine distemper virus.

Authors:  M Appel; D S Robson
Journal:  Am J Vet Res       Date:  1973-11       Impact factor: 1.156

7.  Cell-mediated immunity and age at vaccination associated with measles inoculation and protection of dogs against canine distemper.

Authors:  J D Gerber; A E Marron
Journal:  Am J Vet Res       Date:  1976-02       Impact factor: 1.156

8.  Use of alveolar macrophages for cultivation of canine distemper virus.

Authors:  M J Appel; O R Jones
Journal:  Proc Soc Exp Biol Med       Date:  1967-11

9.  Serologic response to canine distemper viral antigens in gnotobiotic dogs infected with canine distemper virus.

Authors:  S Krakowka; R Olsen; A Confer; A Koestner; B McCullough
Journal:  J Infect Dis       Date:  1975-10       Impact factor: 5.226

10.  Natural and immune cytolysis of canine distemper virus-infected target cells.

Authors:  W R Shek; R D Schultz; M J Appel
Journal:  Infect Immun       Date:  1980-06       Impact factor: 3.441

View more
  33 in total

1.  Canine distemper virus-immune complexes induce bystander degeneration of oligodendrocytes.

Authors:  C Botteron; A Zurbriggen; C Griot; M Vandevelde
Journal:  Acta Neuropathol       Date:  1992       Impact factor: 17.088

2.  Cytotoxic T lymphocytes and natural killer cell activity in the course of mengo virus infection of mice.

Authors:  D Hassin; R Fixler; H Bank; A S Klein; Y Hasin
Journal:  Immunology       Date:  1985-12       Impact factor: 7.397

3.  Antibody-induced generation of reactive oxygen radicals by brain macrophages in canine distemper encephalitis: a mechanism for bystander demyelination.

Authors:  C Griot; T Bürge; M Vandevelde; E Peterhans
Journal:  Acta Neuropathol       Date:  1989       Impact factor: 17.088

4.  Spread and distribution of viral antigen in nervous canine distemper.

Authors:  M Vandevelde; A Zurbriggen; R J Higgins; D Palmer
Journal:  Acta Neuropathol       Date:  1985       Impact factor: 17.088

5.  Correlation between humoral immune responses and presence of virus in the CNS in dogs experimentally infected with canine distemper virus.

Authors:  B K Rima; N Duffy; W J Mitchell; B A Summers; M J Appel
Journal:  Arch Virol       Date:  1991       Impact factor: 2.574

6.  Tropism illuminated: lymphocyte-based pathways blazed by lethal morbillivirus through the host immune system.

Authors:  Veronika von Messling; Dragana Milosevic; Roberto Cattaneo
Journal:  Proc Natl Acad Sci U S A       Date:  2004-09-17       Impact factor: 11.205

7.  Studies on canine distemper virus persistence in the central nervous system.

Authors:  C F Müller; R S Fatzer; K Beck; M Vandevelde; A Zurbriggen
Journal:  Acta Neuropathol       Date:  1995       Impact factor: 17.088

8.  Canine distemper virus clearance in chronic inflammatory demyelination.

Authors:  E Bollo; A Zurbriggen; M Vandevelde; R Fankhauser
Journal:  Acta Neuropathol       Date:  1986       Impact factor: 17.088

9.  Macrophage Fc receptors control infectivity and neutralization of canine distemper virus-antibody complexes.

Authors:  M J Appel; S G Mendelson; W W Hall
Journal:  J Virol       Date:  1984-09       Impact factor: 5.103

10.  A ferret model of canine distemper virus virulence and immunosuppression.

Authors:  Veronika von Messling; Christoph Springfeld; Patricia Devaux; Roberto Cattaneo
Journal:  J Virol       Date:  2003-12       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.